We actively pursue research in cardiovascular disorders affecting Singaporeans.
Specific areas of interest include :
- Non-invasive evaluation of systolic and diastolic cardiac function & electrocardiology
- Mitral valve regurgitation
- Pericardial disease
- Novel atherosclerotic risk factors
- Radiologic imaging of coronary and thoracic atherosclerosis
- Angiogenesis
Manuscripts - Year 2005
- Instant dissolution of thrombus by intracoronary abciximab.
Lee CH, Ho KT, Tan HC.
Int J Cardiol 2005; 104: 102-3.
- Does X-sizer thrombectomy abrogate the inferior outcomes in patients with
impaired TIMI flow before mechanical reperfusion for acute myocardial infarction?
Lee CH, Tan HC, Soon CY, Teo SG, Chan H, Permana BA, Sutandar A, Lim YT.
Int J Cardiol 2005; 103: 212-3.
- Safety and feasibility of X-sizer
facilitated rescue percutaneous coronary intervention: a preliminary experience.
Lee CH, Tan HC, Teo SG, Sutandar A, Lim YT.
J Invasive Cardiol 2005; 17: 1-4.
- Pseudo-no-reflow phenomenon in ostial saphenous
vein graft intervention using FilterWire EX protection. Int J Cardiol. 2005;
Lee CH, Tan HC, Lim YT.
104: 233-4.
- Impact of reversibility of no-reflow phenomenon on 30-day mortality
following percutaneous revascularization for acute myocardial infarction -
insights from a 1328 patient registry.
Lee CH, Wong HB, Tan HC, Zhang JJ, Teo SG, Ong HY, Low A, Sutandar A, Lim
YT.
J Interv Cardiol.2005; 18: 1-6.
- Impact of glycemic control on occurrence of no-reflow and 30-day outcomes in
diabetic patients undergoing primary angioplasty for acute myocardial infarction.
Lee CH, Teo SG, Wong HB, Hong CT, Low A, Sutandar A, Tan HC, Lim YT.
J Invasive Cardiol.2005; 17: 422-6.
- Free coronary perforation after X-sizer
thrombectomy: experience of two cases and review of the literature. J Invasive
Lee CH, Wong PS, Tan HC, Lim YT.
Cardiol. 2005; 17: 445-8.
- An Update on Drug-eluting stent in prevention of
restenosis.
Lee CH, Tan HC, Lim YT.
Asian Cardiovasc Thorac Ann. 2006; 14: 75-82.
- Procedural success and 30-day outcomes between CYPHER and TAXUS stent
implantation for the treatment of bifurcation lesion – a single center experience.
Lee CH, Tan HC, Wong HB, Zhang JJ, Soon CY, Teo SG, Low A, Lim YT.
J Invasive Cardiol. 2006; 18: 39-42.
- Late Angiographic Stent Thrombosis
(LAST) of polymer-based paclitaxel-eluting stent.
Lee CH, Lim J, Low A, Tan HC, Lim YT.
Heart 2006; 92: 551-553.
- An
inverse relation between diastolic blood pressure and long-term outcomes in
patients undergoing pharmacoinvasive therapy for myocardial infarction: J-shape
relation in contemporary era of revascularization.
Lee CH, Foo D, Wong HB, Hong E, Seow SC, Ng KS, Lim YT, Tan HC.
J Cardiovasc Med.(in press)
- CYPHER versus TAXUS
stent for bifurcation lesions beyond 30 days – long-term follow-up results.
Lee CH, Low A, Lim J, Wong HB, Lim YT, Tan HC.
Int J
Cardiol. (in press)
- Hemodynamic significance of mitral stenosis: use of a
simple, novel index by 2-dimensional echocardiography.
Seow SC, Koh LP, Yeo TC
J Am Soc Echocardiogy.
2006 Jan;19(1):102-6.
- Atrioventricular conduction block induced by low-dose atropine.
Chin KJ, Seow SC.
Anaesthesia. 2005 Sep;60(9):935-6. No abstract available.
- Severe mitral regurgitation due to annular abscess fistulating into the left atrium.
Wong PS, Yang H, Ling LH.
Heart 2005 No abstracts available
- Transesophageal Echocardiography During Mitral Valve Repair Underestimates
Mitral Valve Area by Pressure Half-time Calculation.
Poh KK, Hong Eric, Yang H,
Lim YT, Yeo TC
International Journal of Cardiology
- Myocardial ischaemia in an adult patient with anomalous left coronary artery
from the pulmonary artery. Soon CY, Wee EWL, Tan HC.
Heart 2006 No abstracts available
- Noncompaction cardiomyopathy presenting with congestive heart failure during
intercurrent dengue viral illness: Importance of phenotypic recognition.
Neo HY,
Wong RCC, Seto KY, Yip JWL, Yang H, Ling LH.
International Journal of
Cardiology 2005
- Impact of glycemic control on occurrence of no-reflow and 30-day outcomes in
diabetic patients undergoing primary angioplasty for myocardial infarction.
CH Lee, SG Teo, E Hong, HB Wong, AFH Low, A Sutandar, HC Tan, YT Lim.
Journal of Invasive Cardiology
- RAPOR: Insights from the Multi-Center Use of Abciximab in Asia.
KK Poh, HC
Tan, JWL Yip, YT Lim.
Singapore Medical Journal
- High grade atrioventricular block from low-dose atropine.
Chin KJ, Seow SC;
Anaesthesia
- Compression of left main coronary artery by dilated pulmonary artery in primary
pulmonary hypertension.
Ng M, Mark Chan MY, Yip JW.
European Heart Journal
(in press)
- Antecedent risk factors and their control in young patients with a first myocardial
infarction.
Chan MY, Chia BL, Wong HB, Woo KS, Sutandar A, Tan HC.
Singapore
Medical Journal (in press)
- Fluvastatin: Efficacy and safety in reducing cardiac events.
Chan MY, Lee CH.
Expert Opinion on Pharmacotherapy (in press)
- Outcomes after percutaneous coronary interventions in patients with chronic
kidney disease.
HC Tan.
J Geriatric Cardiology 2005; 2: 183-7
- Predictors of Bleeding Complication and Thrombocytopenia with the use of
Abciximab during Percutaneous Coronary Intervention.
Razakjr OA, Tan HC,
Yip WL, Lim YT;
Journal of Interventional Cardiology 2005; 18(1), 27-31
- Clinical predictors of a positive troponin T test in patients presenting with probable
acute coronary syndromes.
AR Omar, Chai Ping, HC Tan, YT Lim;
Medical Journal
of Malaysia 2005; 60(1), 50-53.
- Discordant ANP and BNP levels in lone atrial fibrillation.
Ellinor PT, Low AF,
Patton KK, Shea M, MacRae CA;
Journal of the American College of Cardiology.
2005 Jan 4; 45(1): 82-6.
|
